Dr Catherine Jia-Yun Tsai

Research Fellow

In: Molecular Medicine and Pathology » Medical Science » Faculty of Medical and Health Sciences

Committees/Professional groups/Services

FMHS-PGSA

Selected publications and creative works (Research Outputs)

Khan, L. B., & Tsai, J. I. A.-Y. U. N. C. (2019). A simple, cost-effective undergraduate workshop based on simulated complement fixation test to teach the concept of complement system. European Journal of Health and Biology Education, 8 (1), 19-30. 10.12973/ejhbe.8.1.19
Loh, J. M. S., Lorenz, N., Tsai, C. J.-Y., Khemlani, A. H. J., & Proft, T. (2019). Publisher Correction: Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses.. Scientific reports. 10.1038/s41598-019-43123-8
URL: http://hdl.handle.net/2292/42390
Other University of Auckland co-authors: Thomas Proft, Jacelyn Loh, Natalie Lorenz
Khan, L. B., & Tsai, J. Y. C. (2019). A simple, economical and effective ELISA using simulated serum sample for teaching the concept and application of antigen–antibody interactions in undergraduate laboratory. Journal of Biological Education, online first10.1080/00219266.2019.1609552
URL: http://hdl.handle.net/2292/48180
Wagachchi, D., Tsai, J.-Y. C., Chalmers, C., Blanchett, S., Loh, J. M. S., & Proft, T. (2018). PilVax - a novel peptide delivery platform for the development of mucosal vaccines. Scientific Reports, 8, 1-12. 10.1038/s41598-018-20863-7
URL: http://hdl.handle.net/2292/44741
Other University of Auckland co-authors: Thomas Proft, Jacelyn Loh
Wagachchi, D., Tsai, J.-Y. C., Chalmers, C., Blanchett, S., Loh, J. M. S., & Proft, T. (2018). PilVax - a novel peptide delivery platform for the development of mucosal vaccines.. Scientific reports. 10.1038/s41598-018-20863-7
Other University of Auckland co-authors: Thomas Proft, Jacelyn Loh
Blanchett, S. D., Proft, T., Loh, J., & Tsai, C. (17/10/2017). PilVax: A novel peptide carrier for the development of vaccines against tuberculosis. Poster presented at 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases 2017, Denarau Island, Fiji. PilVax – a novel peptide antigen delivery strategy for vaccine development.
URL: http://hdl.handle.net/2292/41258
Other University of Auckland co-authors: Thomas Proft
Loh, J., Tsai, J.-Y., & Proft, T. (2017). The ability of Group A streptococcus to adhere to immortalized human skin versus throat cell lines does not reflect their predicted tissue tropism. Clinical Microbiology and Infection, 23 (9), 677.e1-677.e3. 10.1016/j.cmi.2017.03.011
URL: http://hdl.handle.net/2292/42017
Other University of Auckland co-authors: Jacelyn Loh, Thomas Proft
Loh, J. M., Lorenz, N., Tsai, C. J.-Y., Khemlani, A. H. J., & Proft, T. (2017). Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses. Scientific Reports, 710.1038/s41598-017-07602-0
URL: http://hdl.handle.net/2292/43995
Other University of Auckland co-authors: Jacelyn Loh, Thomas Proft, Natalie Lorenz